Dr Virginie Rozot
Research Officer, SATVI
Virginie Rozot is a Research Officer at the South African TB Vaccine Initiative (SATVI). She is a certified biotechnology technologist and holds both a biotechnology engineering diploma and a PhD. Using these skills, she developed and optimised the first CyTOF2 Mass Cytometry platform on the African continent. The platform has been used to perform deep immuno-phenotyping and functional assessment of peripheral blood leukocytes, to analyse broncho-alveolar lavage samples, and recently, to study immune responses to TB in tissues derived from post-mortem sampling. Her research interests include the TB host-pathogen relationship as well as subsequent immunopathology, with a focus on translating immunological findings into clinical practice.